VEA
CRDF icon

Virtus ETF Advisers’s Cardiff Oncology CRDF Stock Holding History

Virtus ETF Advisers’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,770
Closed -$172K – 384
2021
Q3 		$172K Sell
25,770
-1,344
-5% -$8.44K 0.08% 304
2021
Q2 		$180K Buy
27,114
+12,329
+83% +$105K 0.07% 385
2021
Q1 		$137K Buy
14,785
+252
+2% +$3.06K 0.06% 348
2020
Q4 		$261K Buy
+14,533
New +$255K 0.11% 295

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's CRDF Position: Q4 2021 in Review

Virtus ETF Advisers sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 25,770 shares — an estimated $172K sold.

Virtus ETF Advisers first reported a position in CRDF in Q4 2020 and held it in 4 quarters. The position peaked at $261K in Q4 2020. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Virtus ETF Advisers reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 25,770 Cardiff Oncology shares in Q4 2021, an estimated $172K.
  • Virtus ETF Advisers first reported a position in Cardiff Oncology in Q4 2020 and held it in 4 quarters.
  • Virtus ETF Advisers's Cardiff Oncology position peaked at $261K in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.